Meanwhile, the results showed that dermal MSCs (DMSCs) could significantly inhibit the skin-homing activity of CD8+ T lymphocytes, suggesting that DMSCs might be concomitantly applied to improve the transplantation efficiency and therapeutic efficacy of autologous melanocytes in treating vitiligo [61]. Here, CD8A is linked to vitiligo.